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m1003121 LeftVentricularApicalRemodelingInChagas’HeartDiseaseDlsrupteTheOptimalGlobal
Prolate-EllipsoidLVGeometry- EvidenceFrom
e QuantitativeEchocerdiographicRegionalsnd
GlobalShepeAnalysisStudy
A. Patel,C.Lima,A. Parrc,M.Arsenault,M.Vannan,N.Pandian.
CampinasHealthCtr,SaoPaulo,Brszil,Tufts-NewEnglandMedical
CentecBoston,Mass,USA
LV dysfunctionis knownto occur in Chagas’heartdisease(CD)but the
praciaachangesin regionaland globalLVshapeassociatedwithCD and
their relationto LVfunctionhavenotbeendefined.Toassessthis,weused
quantitativeshapeanalysisIn 2-D echostudiesof 43 pts withCD and20
normais(NL). In the apicai long-~is views,we quantifiedthe following:
regionalgeometryby endocardialcurvature(C, unitless),globalshapeby
FourierShapePowerIndex(FSPI,unltless)andchamberelongationbythe
third oompcnent(F3). Fromthe 4 chamberviews,end-ciiastolic(ED)and
end-systolic(ES)volumes(V)and LVEFwereobtained.Results(Mean+
SEM)
NL CD NL CD
ESC-APex 29+ 1 20+ 2* FSPI-ED 17*1 10 *2*
ESC-Seplum 8*1 10* 1 FSPI-ES “31*4 13* 1’
ESC-Posteriorwslt –4 * 1 -6* 1 F3-ED 0.37+0.02 0.26+0.01”
F3-ES 0.44+0.03 0.31 *0.02*
(*P < 0.05 vs. NL)
EDV(co)inCDwas121l IOVS.S7+ 6 inNL(p=O.045);%LVEFwae41
+ 3 inCDvs.77 + 2 in NL(p < 0.0001).InCD,1)ReducedES-Cofapexis
consistentwithapicalaneurysm.Nootherregionalcuwaturechangeswere
seen.2) DecraasadFSPIand F3 are consistentwithglobularLVand loss
of ellipticalshape.Conclusion:Quantitativeevaluationof LVshapein CD
demonstratesregionalapicaldeformationaewellasdisruptionof theoptimal
globalprolate-ellipsoidshape,whichmaycontributeto LVdysfunction.
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m1004105 AnalysisofTransmuralMyocardialIntensityProfilesProducedbyNewpodecafluoropentene
Microbubbles:ImplicationsRegarding
Determinantsof Opacificetion
K.Ohmori,B.Cotter,O.L.Kwan,A.N.DeMaria.UnivemityofCalifonriaat
SanDiego,SanDiego,CA,USA
Previousmicrospherestudieshavademonstratedthatthetranemuraldistri-
butionof myocsrdialflow in anesthetizeddogs is homogeneous,whereas
vasculardensityincreasesfrom subepicardium(EPI)to subandccardium
(ENDO).Tharefore,the transmuraldistributionof contrastintensityshould
reflaotthe relativeroleof flowandvaecularvolume in producing myccardial
opacification. Westudied transmural intensities after injecting 0.15mlikgIV
ofa newpreactivated odacafluompentanemicrcbubbleQW7437(SONUS)
capableofprolongedmyocardialenhancement.Weperformadvidecintensity
analysisonenddiastolicmidventricularshort-exieimageein 6 anesthetized
dogs.First,a rectangularegionof interset(ROI)enmmpseaadtheseptum
andintensity(O-255graylevels(GL))wsemeasuredevery30sacfor5 min.
An intensitygradientincreasingfrom RVtc LV ENDOwasobserved(Fig.
Iaft).The maximalslopefor pixelintensityverausdiatenoefromRVENDO
was4.6 + 2.6 GUmmat 1.5 + 0.Smin after injection.Next,to studythe
entireLV,time-intensitycurveswareobtainedfromENDOandEPIhalvesof
thaentireLVcircumference.Peakbackgroundsubtractedintenaityoccurred
at 2 minfor bothENDO(29 + 17 GL)and EPI(21+ 12GL)(p < 0.0001)
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andENDO/EPlratiowas1.39+ 0.21(Fig.right).
Thus,QW7437resultsin increasingtransmuralintensitiesfrom EPI to
ENDO.Thesedata suggestthet myocardialopacificationby QW7437is
relatedmorecloselyto vasculardensitythanbloodflow.
[IOO4-106I*fe~andEfiic5cy 0fQWT*7, a NeW
Fluorocarbon-BasedEchocardiographic
ContraatAgent
M.L.Main,J.F.Esc@a.r,S.A.Hall,P.A.Graybum.Universityof Texas
SouthwesfemandDepartmentof Veteran’sAffairsMedicalCenters,Dallas,
TX,USA
Dodacafluoropentane(DFP)emulsionis a phaseshiftechocontrastagent
whichcpscifiesthemyocardiumaftervenousinjectionatdoseswhichdonot
impairhemcdynamioa.QW7437(QW)isanelectricallyalteradDFPmolecule
whichcarriesa netnegativecharge.Thisreedificationofferstwotheoretical
advantagesinenhancingmyocardialopacificatiom1)reducedadherenceto
the negativelychargedvascularendotheliumand 2) reducedmlcrcbubble
maleecence.Wecxmductadastudyin9opsncheatdogstoassessthesafety
endafficacyofthisnoveiagent.HemodynamicparametersIncludlngHR,BP,
PApressure,PCWP,ABG,and ce.rdiacoutputweremeasuredbeforeend
seriallyafterbolusvenousinjectionof 0.05milkgQW.Regionalmyocardial
bloodflow(RMBF)wasmeasuredbeforeandaftercontrastinjeotionusing
microsphere.End-systolicehortaxis imageswereacquiredusingan ATL
HDI3000modifiedfor harmonicimaging.The LADwasthenoocludadand
rapeatcontractecho imagingwas parformedin both fundamental(FND)
andharmonic(HRM)modes.Monastralbluewastheninjactedintothe left
atriumfor pathologicriskarea(PRA)determination.Nosignificantchangea
occurredfollowingcontrastinjectionin eitherhemodynamicparametersor
RMBF.Dense,globalmyocardialopacificationwasobservedforgreaterthan
2 minutesin all subjecte.Backgroundsubtractedvideointensityincreased
eignificentlyinoa mid-anterior(36.5+47.3) andmid-posterior(14.4+ 16.7)
myocardium.Duringexperimentalcoronaryocclueion,meanpathologicnek
area(0.31+ 10)did notdiffersignificantlyfromHRMechoriskarea(ERA)
(0.34+ 14)or FNDERA(0.31& 13)(p= NS).
Conclusion:QW7437opacifiesthe myocardiumafter venousinjection
at doseswhichdo not adverselyaffecthemodynamicsof RMBF.During
experimentalcoronaryocclusion,ERAdoesnotdiffarsignificantlyfromPRA.
-[ QuantiSOn’”,aNevJLcmg-Livinguh~asound
ContraatAaent:Experiencein Human
Volunteera- “
P.A.vanderWouw,A.C.Brauns,M.Levi,S.E.Bailey.AcademicMedical
Centre,Amsterdam,theNetherlandsandAndarisLtd,Nottingham,UK
A dose-findingetudyin humanvolunteerswasmnductedwithQuantison’”,
a newultrasoundcontrastagent,consistingof air-filledcross-linkedalbumin
microcapeules(me).Twelvehealthymalevolunteersagedbetwaen21 and
31 years,werasubjectedto two intravenousdosesof Quantison”’.Thefirst
doseccneistadofeither25,50,100,or 150x l@ mdkg,theseconddoseof
300x 1(Pme/kgwasgiven.30minutesafterthefiratdosa.Echccerdio9mPhic
images(2Dandcolordoppler)weremadewitha VingmedCFMBOOcand
SystemFive,a HawlettPackardSonos1500,andanATLHDI3000.Imagea
weremadeat baseiine,at O,5, 10,15,20,25,30,3S,40,45,50,55,60, 90
and120minutes.Intermittentriggeredimagingwasusedin thraesubjeots.
Machinesettingswereoptimizedfor Quantison’”:maximaloutput power,
optimalfraquenoytransducer,andfocusinthefar fiald.Quantison’”muld be
clearlyvisualizedintheLVcavity,withtheSonos1500,HDI3000andSystem
Five,andwiththe CFMSOOcif operatedin a speoialmodeallowinghigher
ultmcund output.Intramycaardialmntrastbaoamevisibiewith intermittent
triggeredimagingin the three subjectewherethis mode waa uaed.The
ocntreatwaevieiblein the LVcavityfor up to 30 mirwtasin 2D and up to
SOminutesin colordoppler.Quantison”’is an uniquenewoontrastagent,
requiringhigherultreaoundoutputforvisualisation,butprovidinglong-lasting
clearintra-oavitsryechocontrastin fundamentalmode.
11OO4-108IMicrospngeEChOcOntraStEnhanceaLefi
HeartandMyocardialPerfusionStudies
W.J.Bommer,M.T.Galloway,R.K.Yamamoto,R.E.Short,E.G.Ticknar.
UnivereityofCalifornia,Davis,USA
Althoughcontrastachocardiographyhas the potentialto providemyocar-
dial perfusionimagingduringrest and stressechocardiography,currently
availableagentshaveshowna reducedpersistencewhenexposedto high
pressuresor highultrasoniclevels.Toovercomethis microbubblefragility,
wedevelopedgelatin-based(5microndiameter)nricrospongea.Electronmi-
crocopy confirmedthapresenceof multiple(100nanometerdiameter)gas
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filled bubbles within a sponge like gelatin matrix. In vitro ultrasonic testing
revealed a reflected digital echo intensity comparable to that of air filled al-
bumin microbubbles. However, the n’ricrospongedigital ultrasound intensity
persisted considerably longer during ultrasound exposure; rrrbosponge in-
tensity half-life 200 see, albumin microbubble half-life 2 sec. In vivo testing
in 4 dogs revealed left heart and myocardial nricrosponge persistence half-
times of 200 to 300 sec compared to albumin microbubble half-times of 3-5
sec. Thus a newly developed rnicrosporrge echo-contrast agent produces
a bright contrast echo effect and appears to resist pressure and ultrasonic
collapse. Thia new agent shows a 100 fold greater myooardial and left heart
persistence. These microspongesconsiderably enhance myocardial perfu-
sion studies.
m1004109 Antigen Binding Cheractsrlatics of AntibodiesCoupled to Targeted Acoustically Reflective
Immunolipoaomes
M.E. Klagerman, S.M. Demos, H. Alkan-Onyuksel, B.J. Kane,
D.D. McPherson. UrriversifyofIllinois-Chicago,Chicago,IL.,Northwestern
Universi~Chicago,IL, USA
We have demonstrated acoustically reflective Iipoaomes targetad success-
fully to fibrin-bearing structures by covalent coupling to polyclonal rabbit
lgG antibodies that react equally with fibrinogen and fibrin (Am Diagnos-.
tics, #313R). Enhanced aoouetic imaging was demonstrated in vitro and
in vivo using a miniswine model of induced atherosclerosis. To determine
the effective antibody affinity requirkxi for successful Iiposome targeting, the
ability of the antibody preparation to increasing bind 1’= fibrinogen in the
preeenoa of increasing quantities of unlabeled fibrinogen (double-antibody
radioimmunoaasx+yprotocol) was assessed at three temperatures (4, 24 and
37QC).
Ffesuks:Two major orders of binding affinity were found: high (Id M-l)
and low (6 x 10% x 107 M-’). Higher affinity antibodies showad moderate
negative enthalpy and high positive entropy, indicating hydrophobic interac-
tions whereas lower affinity antibodies showed high negative enthalpy and
moderate negative entropy, indicating ionic interactions.
Conclusions:Our results suggest that acoustically reflective Iiposomes
can be targetad for site specific imaging using low-affinity antibodies with
major implications for their use for multistructure targeting, acoustic en-
hancement and drug delivery.
~ .afetyandEffi.acy OfAFOISOforCardiac
Contraat Enhancement in Normal Subjects:
Initiel Reeults of a Phase I Clinical Trial
B. Cotter, S. Mulvagh O.L. Kwan, S. Batra2, P.Manspeaker2,
T.J. Pelura2, P.T.Leese2, A.N. DeMaria. Universityof CaliforniaatS8n
Diego,MayoClinic,USA,2UniversifyofCaliforniaat SanDiago,Allisnce
PharrnsceuticalCorp.,USA
AFO150(lmagen@ US,Alliance Pharmaceutical Corp.) isanewpsrfluorohexane-
stabilized uitraaound oontraet agent that have demonstrated to produce in-
tense LV cavity and myocardial opacification following IV injections in ani-
mals. To determine the clinical safety and efficacy of this agent, a Phase I
study was undertaken in 64 healthy volunteera. 20subjscta received placebo
and 44 received incremental doses of AF0150 (0.125, 0.50, 2.0 and 4.0
m~kg. Cardiac imaging was obtainad with commercial instruments at 3.5
MHz in the paraatemal short axis or apical views. Safety assessments in-
cluded BP, HR, ECG, ventilator status, O#3at., CBC, chemistries, coagula-
tionand urine analysis. Alleubjacts tolerated all the injeotionswithout adverse
events and no clinically significant changes in the parameters obtainad were
observed. Echo revealed, at every dose, dense and total opacifioation of the
LV cavity following transient cavity and myocardial shadowing. Myocardial
opacifioation was visible in non-shadowed segments after all injections in
each subject. Vidaodeneitometry, 4 mm radius ROI positioned in the mid
wall of non-shadowed segments revealad an increase from baseline of 21 to
66, 40 and 49 gray levels at the incremental doses of 0.125, 0.50 and 2.0
m@g, reW@OfivelY.Thus AFO150produces dense LVcavity and myooardial
opaoifioation in normal subjects without significant adverse effects or clinical
or Iaboratoty abnormalities. This agent should prove useful for the clinical
assessment of myooardial perfusion.
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Influence of Ultrasonic Energy on Contrast
Echocardiography: Intermittent Imaging Using
AF0150 Yielda Generalized Mvocardial
Opaclfication While Continuok Imaging
Delineatea Intramyocardial Veasela
B. Cotter, K. Ohmori, A. Duong, O.L. Kwan, A.N. DeMaria. Universityof
Californiaat SanDiego,USA
AFO150(Imagent”, Alliance) is an intravenous contrast agent that has bean
fQUnd to produca linear or punctate signals compatible with intramyocardial
vessels rather than a diffuse myocardial blush during second harmonic (2H)
imaging. We have demonetratad that bubble destruction by amustic energy
was increased during low velocity flow. We hypothesized that continuous
(CONT) insonification destroyad bubbles in the low velocity microcircula-
tion but not in higher velocity vessels, and that this phenomenon muid be
reversed by intermittent imaging. Therefore, we mmpared CONT with ECG-
gatad imaging in 8 dogs given 1.5 mL of AFO150 IV. Shorl axis echo at the
mid-papillary level wae performed using different instruments capable of 2nd
H imaging bytransmiffing from 1.8 to2.5 MHzand receiving between 3.6and
5.0 MHz. Pulsed Doppler recordingsware obtainad from the Iinearstructures.
Off line videodensitometry (4 mm2 ROI, O-255 gray levels) was done on the
linear structures and adjacent myocardium. CONT imaging produced linear
or punotate structures compatible with intramyocardial vessels with a mean
inteneity of 96.8 + 55 gray levels (mean + SD), while myocardial intensity
was the same as baseline: 30.8 + 17 GL. Pulsed Doppler reoordinge from
these linear structures yieided predominantly diastolic velocities compatible
with coronary flow. ECG-gated imaging yielded a diffuse myocardial blush
with a mean peak videointensily of 93.4 + 35 GL throughout the wall. Thus,
during 2H imaging of AF0150, mntinuous insonification visualizes intramy-
ocardial vessels while intermittent imaging yields a generalized myocardial
blush. These data suRpoti the concept that lower velocity bubbles in the
microoiroulation are destroyed by acoustic anergy to a greater extent than
those in vessels. This differential response maybe of clinical value.
m .tudieSOfBubble perSiatanCevS~tSndardand
Harmonic Mode Acouetic Pules Preeaure for
Thrss New Echocontraet Agents
K.W. Walker, D.J. Sahn, S.E. Grauer, P. Rafter’, G.A. Pantely, M. Williams,
Y. Park, G.D. Giraud. OragonH/thSciUniu Portland,OR,USA,
1Hewlett-Packard,Co.,USA
We developed a non-recirculating, pressurized in vitro flow model in which
infused contrast echo bubbles flow through a gelatin matrix at a conatant
flow rate. Ultrasound imaging was petiormed with an HP SONOS 26CQ
prototype allowing us to control and to equalize pulses par burst and power
output for standard and harmonic imaging. For continuous or intermittent
gatedexposure, measurements byon-line Acouatic Denaitomet~ and bubble
counts uaing an optical Acusizer’” m770A system were obtained at inlet and
outlet. Three agents were studied: MRX115 (Aerosomes, lmaR); SonoGan
(QW7437, Sonus Pharrn.); and Imagent (AFO 150) (Alliance Pharrn.). MRX
showad a relative threshold for bubble destruction which increased above
a transmit gain of 40 (5.1 wattslcmz spatial peak pulse average). At levels
above this, even gated single burat imaging muld destroy all bubbles already
present within the imaging field (Fig.).
The Alliance agent showed similar characteristics with a destruction
threshold between 1 and 5 watta/cm2. There was no difference between
standard and harmonic imaging rasults for either agent once pulse ~wer
output and pulsas par burst were equalized. The Sonus agent, which mn-
tinuad to generate bubbles in our model at 3P, showed mote variability, but
once stabilized, its sensitivity to ultrasound power paralleled results for the
other agents. Our unique model combines controlled ultrasound power and
exposure as well as optical particle counting to provide insights about the
interaction between ultrasound imaging and bubble persistence.
